A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site.
Saved in:
| Title: | A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site. |
|---|---|
| Authors: | Monzon, Jose G.1 (AUTHOR) jose.monzon@albertahealthservices.ca, Karachiwala, Hatim1 (AUTHOR), Walker, John2 (AUTHOR), Goel, Rakesh3 (AUTHOR), Wheatley-Price, Paul3 (AUTHOR), Asmis, Timothy R.3 (AUTHOR), Navani, Vishal1 (AUTHOR), Tang, Patricia A.1 (AUTHOR), Vickers, Michael M.3 (AUTHOR) |
| Source: | European Journal of Cancer. May2026, Vol. 239, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598049 |
|---|---|
| DOI: | 10.1016/j.ejca.2026.116709 |
